AU6745700A - 49 human secreted proteins - Google Patents
49 human secreted proteinsInfo
- Publication number
- AU6745700A AU6745700A AU67457/00A AU6745700A AU6745700A AU 6745700 A AU6745700 A AU 6745700A AU 67457/00 A AU67457/00 A AU 67457/00A AU 6745700 A AU6745700 A AU 6745700A AU 6745700 A AU6745700 A AU 6745700A
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12660199P | 1999-03-26 | 1999-03-26 | |
| US60126601 | 1999-03-26 | ||
| US15437399P | 1999-09-17 | 1999-09-17 | |
| US60154373 | 1999-09-17 | ||
| US17606400P | 2000-01-14 | 2000-01-14 | |
| US60176064 | 2000-01-14 | ||
| PCT/US2000/007677 WO2000063230A2 (fr) | 1999-03-26 | 2000-03-23 | 49 proteines secretees humaines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6745700A true AU6745700A (en) | 2000-11-02 |
Family
ID=27383444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU67457/00A Abandoned AU6745700A (en) | 1999-03-26 | 2000-03-23 | 49 human secreted proteins |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1171462A2 (fr) |
| JP (1) | JP2002541833A (fr) |
| AU (1) | AU6745700A (fr) |
| CA (1) | CA2364209A1 (fr) |
| WO (1) | WO2000063230A2 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6573095B1 (en) * | 1998-04-29 | 2003-06-03 | Genesis Research & Development Corporation Limited | Polynucleotides isolated from skin cells |
| AU2001232969A1 (en) * | 2000-01-25 | 2001-08-07 | Nuvelo, Inc. | Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| WO2001090357A1 (fr) * | 2000-05-24 | 2001-11-29 | Genesis Research & Development Corporation Limited | Compositions isolees des cellules cutanees et methodes d'utilisation de ces compositions |
| DK1390403T3 (da) | 2001-05-25 | 2007-05-14 | Nymox Corp | Peptider afledt af nervetrådsproteiner og medicinsk anvendelse deraf |
| EA006603B1 (ru) * | 2001-07-19 | 2006-02-24 | Наймокс Корпорейшн | Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток |
| EP1847550A3 (fr) * | 2001-07-19 | 2008-01-09 | Nymox Corporation | Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules |
| US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| KR100535543B1 (ko) * | 2002-09-13 | 2005-12-08 | 현대자동차주식회사 | 스로틀 밸브 동결 방지장치 |
| US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
-
2000
- 2000-03-23 JP JP2000612320A patent/JP2002541833A/ja not_active Withdrawn
- 2000-03-23 AU AU67457/00A patent/AU6745700A/en not_active Abandoned
- 2000-03-23 EP EP00955227A patent/EP1171462A2/fr not_active Withdrawn
- 2000-03-23 WO PCT/US2000/007677 patent/WO2000063230A2/fr not_active Ceased
- 2000-03-23 CA CA002364209A patent/CA2364209A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000063230A3 (fr) | 2001-02-08 |
| WO2000063230A2 (fr) | 2000-10-26 |
| EP1171462A2 (fr) | 2002-01-16 |
| JP2002541833A (ja) | 2002-12-10 |
| CA2364209A1 (fr) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1473501A (en) | 21 human secreted proteins | |
| AU1438001A (en) | 27 human secreted proteins | |
| AU1448701A (en) | 15 human secreted proteins | |
| AU1334101A (en) | 19 human secreted proteins | |
| AU3769700A (en) | 45 human secreted proteins | |
| AU6745700A (en) | 49 human secreted proteins | |
| AU2757500A (en) | 33 human secreted proteins | |
| AU3517000A (en) | 50 human secreted proteins | |
| AU1918601A (en) | 23 human secreted proteins | |
| AU3628600A (en) | 46 human secreted proteins | |
| AU1916101A (en) | 19 human secreted proteins | |
| AU3765500A (en) | 50 human secreted proteins | |
| AU1342501A (en) | 32 human secreted proteins | |
| AU3249300A (en) | 47 human secreted proteins | |
| AU3396600A (en) | 49 human secreted proteins | |
| AU3208700A (en) | 33 human secreted proteins | |
| AU1472801A (en) | 24 human secreted proteins | |
| AU1449001A (en) | 28 human secreted proteins | |
| AU3766800A (en) | 48 human secreted proteins | |
| AU3767300A (en) | 47 human secreted proteins | |
| AU3871300A (en) | 50 human secreted proteins | |
| AU3628700A (en) | 49 human secreted proteins | |
| AU3747000A (en) | 49 human secreted proteins | |
| AU3730500A (en) | 50 human secreted proteins | |
| AU3529000A (en) | 47 human secreted proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |